Scott A. Bibaud - 11 Mar 2026 Form 4 Insider Report for Atomera Inc (ATOM)

Role: CEO and President, Director
Signature: By: Mindi Zimmer, as Attorney-in-Fact For: Scott Bibaud
Issuer symbol: ATOM
Transactions as of: 11 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 13 Mar 2026, 20:03:17 UTC
Previous filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
BIBAUD SCOTT A.	CEO and President, Director	C/O ATOMERA, INC., 750 UNIVERSITY AVENUE, SUITE 280, LOS GATOS	By: Mindi Zimmer, as Attorney-in-Fact For: Scott Bibaud	13 Mar 2026	0001464249

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATOM	Performance Stock Option (right to buy)	Award		+170,920		$0.000000^*	170,920	11 Mar 2026	Common Stock	170,920	$5.10	Direct	F1
transaction	ATOM	Performance Stock Option (right to buy)	Award		+85,460		$0.000000^*	85,460	11 Mar 2026	Common Stock	85,460	$5.10	Direct	F2
transaction	ATOM	Performance Stock Option (right to buy)	Award		+85,460		$0.000000^*	85,460	11 Mar 2026	Common Stock	85,460	$5.10	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $20.00. In the event the $20.00 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.
F2	Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $12.50. In the event the $12.50 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.
F3	Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $7.50. In the event the $7.50 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.